Hussman Strategic Advisors, Inc. Wave Life Sciences Ltd. Transaction History
Hussman Strategic Advisors, Inc.
- $384 Million
- Q1 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 105,000 shares of WVE stock, worth $732,900. This represents 0.22% of its overall portfolio holdings.
Number of Shares
105,000
Previous 42,000
150.0%
Holding current value
$732,900
Previous $519,000
63.39%
% of portfolio
0.22%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$127 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$87.4 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$57.7 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$47 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$44.4 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $606M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...